Literature DB >> 30539320

My best case: homeopathic management of adverse effects of tamoxifen.

Jean-Lionel Bagot1,2,3, Clara Delègue4.   

Abstract

BACKGROUND: Nearly half of patients discontinue tamoxifen hormone therapy early because of side effects, thus increasing the risk of breast cancer recurrence. Could a homeopathic treatment improve compliance?
METHODS: A patient suffering from side effects of tamoxifen was seen in consultation every 2 months for 10 months by a senior homeopathic doctor and a registrar.
RESULTS: Case analysis and repertorisation led to the identification of Pulsatilla as the simillimum drug and tamoxifen 7c as the etiological treatment. This treatment resulted in a rapid and lasting improvement of all the symptoms.
CONCLUSIONS: The combination of a homeopathic medicine and a hetero-isotherapic illustrates both the principles of "similarity" and "the identical". It has proved to be an excellent response to the side effects of tamoxifen. By enhancing the patient's quality of life, this combined approach also improved adherence to treatment.

Entities:  

Keywords:  Breast cancer; Hetero-isotherapy; Homeopathy; Pulsatilla; Side effects

Mesh:

Substances:

Year:  2018        PMID: 30539320     DOI: 10.1007/s10354-018-0672-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  2 in total

1.  Integrative Oncology: An International Perspective from Six Countries.

Authors:  Alain Toledano; Santosh Rao; Moshe Frenkel; Elio Rossi; Jean-Lionel Bagot; Ingrid Theunissen; Gualberto Díaz-Sáez
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

2.  Information Survey on the Use of Complementary and Alternative Medicine.

Authors:  Marco Paoloni; Francesco Agostini; Sergio Bernasconi; Gianni Bona; Carlo Cisari; Massimo Fioranelli; Marco Invernizzi; Antonello Madeo; Marco Matucci-Cerinic; Alberto Migliore; Nicola Quirino; Carlo Ventura; Roberto Viganò; Andrea Bernetti
Journal:  Medicina (Kaunas)       Date:  2022-01-14       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.